Starling Oncology (STLN) Cost of Revenue (2021 - 2026)
Analysis
Starling Oncology (STLN) Cost of Revenue (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.68 Bn | 89.67 Bn | 15.19 Bn | 5.04 Bn |
| 2 | Tenet Healthcare | 22.03 Bn | 19.86 Bn | 4.45 Bn | 1.17 Bn |
| 3 | Encompass Health | 12.07 Bn | 11.93 Bn | 1.34 Bn | 254.90 Mn |
| 4 | Davita | 11.73 Bn | 11.05 Bn | 1.16 Bn | 2.39 Bn |
| 5 | Universal Health Services | 10.15 Bn | 10.01 Bn | 3.29 Bn | 1.35 Bn |
| 6 | Ensign | 9.95 Bn | 9.63 Bn | 306.24 Mn | 1.13 Bn |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 451.78 Mn |
| 8 | Pacs | 6.68 Bn | 6.51 Bn | 338.46 Mn | 1.09 Bn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 413.93 Mn |
| 10 | Starling Oncology | 613.04 Mn | 571.94 Mn | 27.17 Mn | 134.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134.12 Mn |
| Mar 31, 2026 | 124.13 Mn |
| Dec 31, 2025 | -86.54 Mn |
| Sep 30, 2025 | 117.64 Mn |
| Jun 30, 2025 | 102.30 Mn |
| Mar 31, 2025 | 87.16 Mn |
| Dec 31, 2024 | -66.90 Mn |
| Sep 30, 2024 | 85.54 Mn |
| Jun 30, 2024 | 46.52 Mn |
| Mar 31, 2024 | 49.50 Mn |
| Dec 31, 2023 | 48.36 Mn |
| Sep 30, 2023 | 44.96 Mn |
| Jun 30, 2023 | 44.88 Mn |
| Mar 31, 2023 | 42.81 Mn |
| Dec 31, 2022 | 38.38 Mn |
| Sep 30, 2022 | 36.13 Mn |
| Jun 30, 2022 | 32.88 Mn |
| Mar 31, 2022 | 27.38 Mn |
| Dec 31, 2021 | 27.35 Mn |
| Sep 30, 2021 | 25.39 Mn |